Anticancer |
(major) |
Borneol |
Cancer |
NA |
Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-Mediated DNA Damage
see more studies
|
 |
CBD
(Cannabidiol) |
Cancer |
NA |
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
see more studies
|
 |
CBD
(Cannabidiol) |
Glioblastoma multiforme |
NA |
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma |
 |
Caryophyllene |
Cancer |
10.54% of mixture |
Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso |
 |
Geraniol |
Prostate cancer |
NA |
Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells |
 |
Humulene |
Cancer |
32μg/mL |
Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel |
 |
α-Pinene / β-Pinene |
Cancer |
α-pinene (19.43%),
β-pinene (6.71%) |
Antibacterial Activity and Anticancer Activity of Rosmarinus officinalis L. Essential Oil Compared to That of Its Main Components |
 |
Terpinolene |
Breast tumor,
prostate carcinoma |
8.4% of mixture |
Essential oil constituents, anticancer and antimicrobial activity of Ficus mucoso and Casuarina equisetifolia leaves |
 |
THC
(Tetrahydrocannabinol) |
Glioblastoma multiforme |
NA |
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma |
 |
(moderate) |
Camphene |
Cervical cancer |
NA |
The in-vitro evaluation of antibacterial, antifungal and cytotoxic properties of Marrubium vulgare L. essential oil grown in Tunisia |
 |
CBD
(Cannabidiol) |
Cancer |
200mg/kg |
Antineoplastic Activity of Cannabinoids |
 |
CBDA
(Cannabidiolic acid) |
cancer |
NA |
Cannabidiolic acid, a (major) cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration |
 |
Caryophyllene |
Cancer |
7.8–500lg/mL |
Effects of β-caryophyllene and Murraya paniculata essential oil in the murine hepatoma cells and in the bacteria and fungi 24-h time–kill curve studies |
 |
Caryophyllene oxide |
Cancer |
17.90% of mixture |
Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso |
 |
Linalool |
Breast cancer |
NA |
Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells |
 |
Colon cancer |
100μg/kg,
200μg/kg |
Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer |
 |
Prostate cancer |
NA |
Anticancer Activity of Linalool Terpenoid: Apoptosis Induction and Cell Cycle Arrest in Prostate Cancer Cells |
 |
Terpineol |
Cancer |
3 or 6mM |
α-Terpineol: A Potential Anticancer Agent which Acts through Suppressing NF-κB Signalling |
 |
Hepatocellular carcinoma |
10mg/kg,
20mg/kg |
4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest |
 |
Liver cancer |
320μg/ml |
γ-terpineol inhibits cell growth and induces apoptosis in human liver cancer BEL-7402 cells in vitro |
 |
Terpinolene |
Brain tumour |
10mg/L,
25mg/L,
50mg/L,
100mg/L,
200mg/L,
400mg/L |
Anticancer and Antioxidant Properties of Terpinolene in Rat Brain Cells |
 |
(minor) |
Linalool |
Lung cancer |
NA |
A comparative study of cytotoxic, membrane and DNA damaging effects of Origanum (major)ana’s essential oil and its oxygenated monoterpene component linalool on parental and epirubicin-resistant H1299 cells |
 |
Antifungal |
(major) |
Borneol |
Fungal contamination |
NA |
Borneol-grafted cellulose for antifungal adhesion and fungal growth inhibition |
 |
Camphene |
Phytopathogenic fungi |
NA |
Chemical composition and antifungal activity of Artemisia nilagirica essential oil growing in nort |
 |
P-Cymene |
Phytopathogenic fungi |
NA |
Antifungal Effects of Volatile Compounds from Black Zira (Bunium persicum) and Other Spices and Herbs |
 |
Farnesene |
Fungal contamination |
14.6–16.4% of mixture |
Chemical Composition and in vitro Antifungal Properties of Essential Oils from Leaves and Flowers of Erigeron floribundus (H.B. et K.) Sch. Bip. From Cameroon |
 |
D-Limonene |
Fungal contamination |
NA |
Rapid Evaluation of Plant Extracts and Essential Oils for Antifungal Activity Against Botrytis cinerea |
 |
Nerolidol |
Fungal contamination |
NA |
Evaluation of antifungal activity in essential oil of the Syzygium aromaticum (L.) by extraction, purification and analysis of its main component eugenol |
 |
Terpinolene |
Malassezia furfur |
NA |
Chemical Composition and Antifungal Activity of Plant Essential Oils against Malassezia furfur |
 |
(moderate) |
β-Caryophyllene |
Phytopathogenic fungi |
16.98% of mixture |
Chemical composition and antifungal properties of the essential oil and various extracts of Mikania scandens (L.) Willd. |
 |
Cymene |
Phytopathogenic fungi |
2% of mixture |
Antifungal, phytotoxic and insecticidal properties of essential oil isolated from Turkish Origanum acutidens and its three components, carvacrol, thymol and p-cymene |
 |
P-Cymene |
Fungal contamination |
1000ppm |
Studies on Antifungal Properties of Essential Oil of Trachyspermum ammi (L.) Sprague
see more studies
|
 |
Myrcene |
Fungal contamination |
47.7–84.6% of mixture |
Essential oils from Distichoselinum tenuifolium: Chemical composition, cytotoxicity, antifungal and anti-inflammatory properties |
 |
Ocimene |
Fungal contamination |
30.4% of mixture |
Antifungal activity of the essential oil of Angelica (major) against Candida, Cryptococcus, Aspergillus and dermatophyte species
see more studies
|
 |
Phellandrene |
Fungal contamination |
1.7mL/L,
1.8mL/L |
Anti-fungal activity, mechanism studies on α-Phellandrene and Nonanal against Penicillium cyclopium |
 |
Sabinene |
Dermatophytes and Cryptococcus neoformans |
29.% of mixture |
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil |
 |
Fungal contamination |
31.1% of mixture |
In Vivo Antifungal Activity of the Essential Oil of Bupleurum gibraltarium against Plasmopara halstedii in Sunflower
see more studies
|
 |
Terpinolene |
Botrytis cinerea |
NA |
Antifungal modes of action of tea tree oil and its two characteristic components against Botrytis cinerea |
 |
(minor) |
D-Limonene |
Fungal contamination |
56% of mixure,
57.5% of mixure |
Antifungal Activity of Thapsia villosa Essential Oil against Candida, Cryptococcus, Malassezia, Aspergillus and Dermatophyte Species |
 |
Sabinene |
Fungal contamination |
29% of mixture |
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil |
 |
Antiinflammatory |
(major) |
α-Bisabolol |
Edema |
NA |
Anti-nociceptive and anti-inflammatory activities of (−)-α-bisabolol in rodents |
 |
Borneol |
Inflammation |
NA |
Analgesic and Anti-inflammation Effect of Borneol |
 |
CBC
(Cannabichromene) |
Colitis |
NA |
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis |
 |
Edema |
NA |
Anti-inflammatory properties of cannabichromene
see more studies
|
 |
Inflammation-induced hypermotility |
10mg/kg |
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice |
 |
Microbiological contamination |
NA |
Biological Activity of Cannabichromene, its Homologs and Isomers |
 |
CBD
(Cannabidiol) |
Acute Pancreatitis |
0.5mg/kg |
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice |
 |
AD-related neuroinflammation |
2.5 or 10mg/kg |
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression |
 |
Chronic Pain |
2.5–20mg/kg |
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain |
 |
Diabetic Complications |
NA |
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
see more studies
|
 |
Pathological memory T cells and in Autoimmune diseases |
NA |
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells |
 |
Uveitis |
5mg/kg |
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation |
 |
CBG
(Cannabigerol) |
Irritable bowel syndrome |
NA |
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease |
 |
β-Caryophyllene |
Rheumatoid arthritis |
100mg/kg,
300mg/kg |
Anti-Arthritic and Anti Inflammatory Activity of β-Caryophyllene against Freund’s Complete Adjuvant Induced Arthritis in Wistar Rats |
 |
Caryophyllene oxide |
Inflammation |
12.5mg/kg,
25mg/kg |
Analgesic and anti-inflammatory activity of Caryophyllene oxide from Annona squamosa L. bark |
 |
Cymene |
Lipopolysaccharide induced acute lung injury |
NA |
Protective effect of p-cymene on lipopolysaccharide-induced acute lung injury in mice |
 |
Eucalyptol |
Acute lung injury |
100mg/kg,
200mg/kg,
400mg/kg |
Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model |
 |
Airway hypersecretion |
200mg |
Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial |
 |
Humulene |
Edema |
NA |
Anti-inflammatory effects of compounds α-humulene and (−)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea |
 |
Isopulegol |
Edema |
22.02% of mixture |
In Vivo Potential Anti-Inflammatory Activity of Melissa officinalis L. Essential Oil |
 |
Limonene |
Edema |
25mg/kg,
50mg/kg,
75mg/kg |
Physio-pharmacological Investigations About the Anti-inflammatory and AntinociceptiveAntinociceptive Efficacy of (+)-Limonene Epoxide |
 |
D-Limonene |
TNBS-induced intestinal inflammation |
10mg/kg |
Oral administration of d-Limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans |
 |
Linalool |
Inflammation |
NA |
Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model |
 |
Sabinene |
Inflammation |
29% of mixture |
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil |
 |
α-Terpineol |
Edema |
6.2% of mixture |
Chemical constituents and antiinflammatory activity of leaf essential oil of Nigerian grown Chenopodium album L. |
 |
THC
(Tetrahydrocannabinol) |
Friend leukemia virus-induced splenomegaly |
200mg/kg |
Antineoplastic Activity of Cannabinoids |
 |
(moderate) |
α-trans-Bergamotene |
Pleurisy |
7% of mixture |
Pharmacological evaluation of Copaifera multijuga oil in rats |
 |
α-Bisabolol |
Inflammation |
NA |
Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages |
 |
Borneol |
Oral mucositis |
1.2% of mixture,
2.4% of mixture |
Anti-inflammatory and healing action of oral gel containing borneol monoterpene in chemotherapy-induced mucositis in rats ( Rattus norvegicus ) |
 |
Camphor |
Arthritis |
NA |
Study on antiinflammatory effect of different chemotype of Cinnamomum camphora on rat arthritis model induced by Freund’s adjuvant |
 |
CBD
(Cannabidiol) |
Acute lung injury |
20mg/kg |
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor |
 |
Inflammation |
5–40mg/kg |
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw |
 |
Retinal Inflammatory |
NA |
Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor |
 |
Rheumatic diseases |
NA |
Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model |
 |
CBG
(Cannabigerol) |
Neuroinflammation |
NA |
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis |
 |
CBGA
(Cannabigerolic Acid) |
Inflammation |
NA |
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa |
 |
Δ-3-Carene |
Edema |
NA |
Pharmacological activity of the essential oil of Bupleurum gibraltaricum: anti-inflammatory activity and effects on isolated rat uteri
see more studies
|
 |
P-Cymene |
Hyperalgesia,
Pleurisy |
25mg/kg,
50mg/kg,
100mg/kg |
The anti-hyperalgesic and anti-inflammatory profiles of p-cymene: Evidence for the involvement of opioid system and cytokines |
 |
Inflammation |
25mg/kg,
50mg/kg,
100mg/kg |
Evaluation of the Anti-Inflammatory and Antinociceptive Properties of p-Cymene in Mice |
 |
Eucalyptol |
Colitis |
200mg/kg,
400mg/kg |
1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis |
 |
Edema,
Pulmonary inflammation |
NA |
Transient Receptor Potential Cation Channel Subfamily M Member 8 channels mediate the anti-inflammatory effects of eucalyptol |
 |
Edema |
NA |
Antiinflammatory and antinociceptive effects of 1,8-cineole a terpenoid oxide present in many plant essential oils |
 |
Geraniol |
Atherosclerosis |
100mg/kg |
Geraniol attenuates fibrosis and exerts anti-inflammatory effects on diet induced atherogenesis by NF-κB signaling pathway |
 |
Isopulegol |
Edema |
NA |
Anotinociceptive and anti-inflammatory potential of Isopulegol and possible mechanisms of action in rodents |
 |
Linalool |
Edema |
NA |
α-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2 |
 |
Neuropathic pain |
NA |
(–)‐Linalool Attenuates Allodynia in Neuropathic Pain Induced by Spinal Nerve Ligation in C57/Bl6 Mice |
 |
Menthol |
Chronic inflammatory disorders such as bronchial asthma, colitis and allergic rhinitis |
NA |
The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases |
 |
Myrcene |
Inflammation |
47.7–84.6% of mixture |
Essential oils from Distichoselinum tenuifolium: Chemical composition, cytotoxicity, antifungal and anti-inflammatory properties |
 |
β-Myrcene |
Osteoarthritis |
NA |
Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis |
 |
Phellandrene |
Pro-inflammatory cytokines TNF-α and IL-6 |
50mg/kg,
100mg/kg,
200mg/kg |
α-Phellandrene, a cyclic monoterpene, attenuates inflammatory response through neutrophil migration inhibition and mast cell degranulation |
 |
Phytol |
Edema |
7.5mg/kg,
25mg/kg,
50mg/kg,
75mg/kg |
Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress |
 |
α-Pinene / β-Pinene |
Inflammation |
NA |
α-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages |
 |
Sabinene |
Lipopolysaccharide plus interferon gamma triggered macrophages |
29.% of mixture |
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil |
 |
Terpineol |
Edema |
NA |
A Study on Anti-Inflammatory and Peripheral Analgesic Action of Salvia sclarea Oil and Its Main Components |
 |
Terpineol-4-ol |
LPS-stimulated human macrophages |
NA |
Terpinen-4-ol and α-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages |
 |
THC
(Tetrahydrocannabinol) |
Intestinal inflammation |
NA |
Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques |
 |
Ischaemia-reperfusion injury |
NA |
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors |
 |
(minor) |
CBD
(Cannabidiol) |
Neuroinflammatory diseases |
NA |
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells |
 |
Sepsis |
NA |
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase |
 |
CBDA
(Cannabidiolic acid) |
Inflammation |
2μM |
Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis |
 |
Caryophyllene |
Parkinson’s disease |
50mg/kg |
β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease |
 |
Eucalyptol |
Mosquito larvae |
100mg/L |
Bioactivity of Dianthus caryophyllus, Lepidium sativum, Pimpinella anisum, and Illicium verum essential oils and their (major) components against the West Nile vector Culex pipiens |
 |
THC
(Tetrahydrocannabinol) |
Crohn’s Disease |
115mg |
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study |
 |
Edema |
NA |
Antipyretic, analgesic and anti-inflammatory effects of Δ9-tetrahydrocannabinol in the rat |
 |
Antimicrobial |
(major) |
Camphene |
Inflammation and pain-related processes |
NA |
Antinociceptive Activity and Redox Profile of the Monoterpenes (+)-Camphene, p-Cymene, and Geranyl Acetate in Experimental Models |
 |
Farnesene |
Microbiological contamination |
51.5% of mixture |
Chemical Composition, Antioxidant Properties, α-Glucosidase Inhibitory, and Antimicrobial Activity of Essential Oils from Acacia mollissima and Acacia cyclops Cultivated in Tunisia |
 |
D-Limonene |
Food-related microorganisms |
NA |
Effects of nisin on the antimicrobial activity of d-limonene and its nanoemulsion |
 |
Phellandrene |
Hypernociception |
50mg/kg |
Antinociceptive activity of the monoterpene α-phellandrene in rodents: possible mechanisms of action |
 |
α-Pinene / β-Pinene |
Microbiological contamination |
10.5 % of mixture |
Antimicrobial activity of the essential oil and different fractions of Juniperus communis L. and a comparison with some commercial antibiotics |
 |
Terpineol |
Microbiological contamination |
NA |
Antimicrobial effect of vapours of terpineol, (R)-(–)-linalool, carvacrol, (S)-(–)-perillaldehyde and 1,8-cineole on airborne microbes using a room diffuser |
 |
(moderate) |
Borneol |
Microbiological contamination |
4.91% of mixture |
Chemical Composition and Antimicrobial Activity of Essential Oil of Thyme (Thymus vulgaris) from Eastern Morocco |
 |
Camphene |
Microbiological contamination |
NA |
The in-vitro evaluation of antibacterial, antifungal and cytotoxic properties of Marrubium vulgare L. essential oil grown in Tunisia |
 |
CBC
(Cannabichromene) |
Microbiological contamination |
NA |
Antibacterial Cannabinoids from Cannabis satiWa: A Structure-Activity Study |
 |
Caryophyllene |
Microbiological contamination |
7.8–500lg/mL |
Effects of β-caryophyllene and Murraya paniculata essential oil in the murine hepatoma cells and in the bacteria and fungi 24-h time–kill curve studies |
 |
Caryophyllene oxide |
Microbiological contamination |
60 to 80μg/ml |
Compositions and antimicrobial activities of the essential oils of two Hypericum species from Turkey |
 |
β-Cedrene |
Microbiological contamination |
6.1% of mixture |
Chemical Composition, Antioxidant, Antimicrobial and Cytotoxic Activities of Essential Oil from Premna microphylla Turczaninow |
 |
P-Cymene |
Microbiological contamination |
32.6mL/L |
Chemical composition and in vitro antimicrobial activity of the essential oil of Origanum minutiflorum O Schwarz & PH Davis
see more studies
|
 |
Isoborneol |
Microbiological contamination |
14.66% of mixture |
Essential Oil Composition, Antimicrobial and Pharmacological Activities of Lippia sidoides Cham. (Verbenaceae) From São Gonçalo do Abaeté, Minas Gerais, Brazil |
 |
D-Limonene |
Microbiological contamination |
94% of mixture |
Orange Essential Oils Antimicrobial Activities against Salmonella spp. |
 |
Myrcene |
Microbiological contamination |
NA |
Antimicrobial activity of the essential oil and different fractions of Juniperus communis L. and a comparison with some commercial antibiotics
see more studies
|
 |
α-Pinene / β-Pinene |
Microbiological contamination |
50μg/mL |
Biological Activities of a-Pinene and β-Pinene Enantiomers
see more studies
|
 |
Terpinolene |
Microbiological contamination |
8.4% of mixture |
Essential oil constituents, anticancer and antimicrobial activity of Ficus mucoso and Casuarina equisetifolia leaves |
 |
(minor) |
α-Bisabolol |
Halatosis |
NA |
The antimicrobial activity of α-bisabolol and tea tree oil against Solobacterium moorei, a Gram-positive bacterium associated with halitosis |
 |
Cedrol |
Microbiological contamination |
6.3% of mixture |
Volatile constituents of propolis from various regions of Greece–Antimicrobial activity |
 |
P-Cymene |
Microbiological contamination |
5.33% of mixture |
Antimicrobial Effect of Lippia sidoides and Thymol on Enterococcus faecalis Biofilm of the Bacterium Isolated from Root Canals |
 |
Guaiol |
Microbiological contamination |
8,2% of mixture |
Chemical composition and evaluation of antibacterial and antioxidant activities of the essential oil of Croton urucurana Baillon (Euphorbiaceae) stem bark
see more studies
|
 |
Myrcene |
Microbiological contamination |
NA |
Antioxidant, antimicrobial and toxicological properties of Schinus molle L. essential oils
see more studies
|
 |
Terpineol |
Periodontopathic and cariogenic bacteria |
NA |
Antimicrobial effect of linalool and α-terpineol against periodontopathic and cariogenic bacteria |
 |
α-Terpineol |
Antimicrobial |
13.0% of mixture |
Antimicrobial Activity of Commercial Samples of Thyme and Marjoram Oils |
 |
Antioxidant |
(major) |
α-trans-Bergamotene |
Oxidative stress |
29.9% of mixture |
Chemical composition, antioxidant and antibacterial activities of essential oils from leaves and flowers of Eugenia klotzschiana Berg (Myrtaceae) |
 |
β-Cedrene |
Oxidative stress |
6.1% of mixture |
Chemical Composition, Antioxidant, Antimicrobial and Cytotoxic Activities of Essential Oil from Premna microphylla Turczaninow |
 |
Farnesene |
Oxidative stress |
51.5% of mixture |
Chemical Composition, Antioxidant Properties, α-Glucosidase Inhibitory, and Antimicrobial Activity of Essential Oils from Acacia mollissima and Acacia cyclops Cultivated in Tunisia |
 |
Myrcene |
Oxidative stress |
NA |
Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells
see more studies
|
 |
Nerolidol |
Oxidative stress |
NA |
Antioxidant evaluation of polyhydroxylated nerolidols from redroot pigweed (Amaranthus retroflexus) leaves |
 |
α-Terpineol |
Oxidative stress |
NA |
Influence of the cultivation system in the aroma of the volatile compounds and total antioxidant activity of passion fruit
see more studies
|
 |
(moderate) |
CBG
(Cannabigerol) |
Oxidative stress |
NA |
Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study |
 |
Caryophyllene |
Oxidative stress |
10.54% of mixture |
Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso |
 |
Parkinson’s disease |
50mg/kg |
β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease |
 |
Caryophyllene oxide |
Oxidative stress |
17.9% of mixture |
Chemical Composition, Antioxidant, Anti-Inflammatory and Anti-Proliferative Activities of Essential Oils of Plants from Burkina Faso |
 |
Cymene |
Oxidative stress |
NA |
Evaluation of p-cymene, a natural antioxidant |
 |
P-Cymene |
Oxidative stress |
NA |
Antimicrobial and Antioxidant Activity of the Essential Oil and Methanol Extracts of Thymus pectinatus Fisch. et Mey. Var. pectinatus (Lamiaceae)
see more studies
|
 |
Guaiol |
Oxidative stress |
8,2% of mixture |
Chemical composition and evaluation of antibacterial and antioxidant activities of the essential oil of Croton urucurana Baillon (Euphorbiaceae) stem bark |
 |
Myrcene |
Oxidative stress |
NA |
Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver
see more studies
|
 |
Nerolidol |
Oxidative stress |
25mg/kg,
50mg/kg,
75mg/kg |
Antioxidant effects of nerolidol in mice hippocampus after open field test
see more studies
|
 |
Sabinene |
Oxidative stress |
29.% of mixture |
Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil |
 |
Terpineol |
Oxidative Stress |
NA |
Evaluation of the antioxidant and antiproliferative potential of bioflavors |
 |
Terpinolene |
Oxidative stress |
11mg/L,
25mg/L,
50mg/L,
100mg/L,
200mg/L,
400mg/L |
Anticancer and Antioxidant Properties of Terpinolene in Rat Brain Cells
see more studies
|
 |
(minor) |
Farnesene |
Superficial scald |
NA |
Superficial scald, a functional disorder of stored apples. V.—Oxidation of α-farnesene and its inhibition by diphenylamine
see more studies
|
 |
Myrcene |
Oxidative stress |
NA |
Antioxidant, antimicrobial and toxicological properties of Schinus molle L. essential oils |
 |
α-Terpineol |
Oxidative stress |
NA |
Antioxidant and antiproliferative activities of essential oils of some wild Portuguese Thymus |
 |
THC
(Tetrahydrocannabinol) |
Oxidative stress |
NA |
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants |
 |
Anxiolytic |
(major) |
CBD
(Cannabidiol) |
Anxiety |
600mg |
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
see more studies
|
 |
Limonene |
Anxiety |
25mg/kg,
50mg/kg,
75mg/kg |
Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action
see more studies
|
 |
Linalool |
Anxiety |
NA |
Evaluation of anxiolytic potency of essential oil and S-(+)-linalool from Cinnamomum osmophloeum ct. linalool leaves in mice |
 |
(moderate) |
CBD
(Cannabidiol) |
Anxiety |
300mg |
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
see more studies
|
 |
Posttraumatic stress disorder |
32mg |
Cannabidiol enhances consolidation of explicit fear extinction in humans
see more studies
|
 |
Caryophyllene |
Depression and anxiety |
50mg/kg |
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
see more studies
|
 |
Limonene |
Anxiety |
3.4mg/L,
6.7mg/L |
Differences in the effects of essential oil from Citrus junos and (+)-limonene on emotional behavior in mice |
 |
Linalool |
Anxiety |
0.65% of mixure,
1.25% of mixure,
2.5% of mixure,
5.0% of mixure |
Anxiolytic-like effects of inhaled linalool oxide in experimental mouse anxiety models |
 |
α-Pinene / β-Pinene |
Anxiety |
NA |
Expression of BDNF and TH mRNA in the Brain Following Inhaled Administration of α-Pinene |
 |
THC
(Tetrahydrocannabinol) |
Anxiety |
NA |
Cannabinoid facilitation of fear extinction memory recall in humans |
 |
Acute psychosocial stress |
7.5mg,
12.5mg |
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress |
 |
Posttraumatic stress disorder |
NA |
Cannabinoid facilitation of fear extinction memory recall in humans |
 |
(minor) |
THC
(Tetrahydrocannabinol) |
Anxiety |
7.5mg,
15mg |
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images |
 |
Neuroprotectant |
(major) |
CBD
(Cannabidiol) |
Brain Injury |
300mg |
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity
see more studies
|
 |
Caryophyllene |
Seizures |
NA |
Neuroprotective Effects of Trans-Caryophyllene Against Kainic Acid Induced Seizure Activity and Oxidative Stress in Mice |
 |
Cerebral Ischemic Injury |
10mg/kg |
Protective Effect of β-Caryophyllene, a Natural Bicyclic Sesquiterpene, Against Cerebral Ischemic Injury |
 |
THC
(Tetrahydrocannabinol) |
Alzheimer’s Disease |
NA |
The potential therapeutic effects of THC on Alzheimer’s disease |
 |
(moderate) |
CBD
(Cannabidiol) |
Alzheimer’s Disease |
NA |
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells |
 |
Huntington’s Disease |
10mg/kg |
Controlled clincal trial of cannabidiol in Huntington’s disease |
 |
Parkinson’s disease |
300mg |
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
see more studies
|
 |
Spinal injury |
20mg/kg |
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury |
 |
CBG
(Cannabigerol) |
Huntington’s Disease |
NA |
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
see more studies
|
 |
CBN
(Cannabinol) |
ALS |
5mg/kg |
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival |
 |
D-Limonene |
Anxiety and pain |
15.21% of mixture |
Neuropharmacological activities of phytoncide released from Cryptomeria japonica |
 |
THC
(Tetrahydrocannabinol) |
Alzheimer’s Disease |
NA |
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study. |
 |
ADHD |
NA |
Oral Δ9-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition: A Case Report |
 |
ALS |
NA |
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset |
 |
Dementia |
3mg |
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial |
 |
Neurological disorders |
NA |
Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants |
 |
Oxidative Stress |
NA |
Reactive oxygen species and p38 phosphorylation regulate the protective effect of Δ9-tetrahydrocannabinol in the apoptotic response to NMDA |
 |
Traumatic Brain Injury |
NA |
Effect of marijuana use on outcomes in traumatic brain injury |
 |
THCA
(Tetrahydrocannabinolic Acid) |
Neurodegeneration |
10μM |
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures |
 |
(minor) |
THC
(Tetrahydrocannabinol) |
Alzheimer’s Disease |
4.5mg |
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. |
 |